Get started
Author

MD Francis P. Worden

Observed names: Francis P. Worden, MD Francis P. Worden,
OpenAlex ID: A5116064523
Combined Positive Score and Cost-Effectiveness of Perioperative Pembrolizumab for Head and Neck Cancer
2026 · Aidan H. Coyle, David W. Hutton, et al. · JAMA Otolaryngology–Head & Neck Surgery · 1
Validation of MyHPVscore
2026 · Jordan Currie, Heather Walline, et al. · Journal of Molecular Diagnostics · 1
PDS0101 With Pembrolizumab in HPV16-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
2026 · Jared Weiss, John Kaczmar, et al. · JAMA Oncology
PDF
A phase II basket trial of DART SWOG S1609: the salivary gland tumor cohort
2026 · Young Kwang Chae, Rosie Sun, et al. · Therapeutic Advances in Medical Oncology
Genome-wide variation in cell-free DNA end-motif entropy predicts immunotherapy response in head and neck cancer
2026 · Ravi Bandaru, Hailu Fu, et al. · Journal of Clinical Investigation
PDF
Late Recurrences Beyond Five Years in Salivary Adenoid Cystic Carcinoma: Implications for Long‐Term Surveillance
2026 · Prarthana J. Dalal, Sarah M. Dermody, et al. · OTO Open
Clinical and genetic characteristics of patients with adrenocortical carcinoma and lynch syndrome
2025 · MD Avilasha Sinha,, MD Katherine I. Wolf,, et al. · Endocrine Abstracts
Works count: 7
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type